Ultrasound could one day play a key role in drug delivery, if researchers can harness the ultrasound beam's cavitation effect, which allows drugs to pass through the protective membranes of cells.
Ultrasound could one day play a key role in drug delivery, if researchers can harness the ultrasound beam's cavitation effect, which allows drugs to pass through the protective membranes of cells.
Mark R. Prausnitz, Ph.D., of Georgia Institute of Technology's School of Chemical and Biomolecular Engineering experimented with living prostate cancer and animal cells. He confirmed that the powerful cavitation effect produces enough force to stimulate cell membrane permeability. The holes close down quickly but allow the entry of therapeutic molecules that are 50 nm in diameter, larger than most compounds used for gene therapy (J Ultras Med Bio 2006:32[6]915-924).
The procedure could find future use in systemic therapy in oncology, particularly for large-molecule drugs that cannot easily move through cell membranes.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.